Medical Care Technologies Inc. (OTCID:MDCE) Advances Melanoma Scan Beta With Next-Week Results Posting
Medical Care Technologies said updated internal evaluation results for its MDCE Melanoma Scan Beta will be posted on the company website next week. The expanded readout covers three technical layers — image intake and quality scoring, body-map registration, and change-over-time comparison — building on a first pass completed September 29 that showed real-world user photographs could move through the workflow.
Key figures
- Drug Name
- MDCE Melanoma Scan Beta
- Regulatory status
- no regulatory clearance; beta-stage development
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.